Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ADAGEN

PEGADEMASE BOVINE

Standard Dose
250 UNITS/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview ADAGEN is listed in Drugs@FDA under application 019818 (BLA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient PEGADEMASE BOVINE Form and strength INJECTABLE;INJECTION - 250 UNITS/ML Sponsor LEADIANT BIOSCI INC Submission history Latest submission status date: 2015-12-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview ADAGEN is listed in Drugs@FDA under application 019818 (BLA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient PEGADEMASE BOVINE Form and strength INJECTABLE;INJECTION - 250 UNITS/ML Sponsor LEADIANT BIOSCI INC Submission history Latest submission status date: 2015-12-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.